Tora Skeidsvoll Solheim
Bakgrunn og aktiviteter
Spesialist i onkologi og overlege ved Kreftklinikken, St. Olavs Hospital.
Førsteamanuensis, Institutt for klinisk og molekylær medisin, Fakultet for medisin og helsevitenskap, NTNU
Utdanning:
- Cand.med ved Universitetet i Bergen 2002
- PhD, NTNU 2014
Forskningsinteresser:
- Kreft kakeksi: Behandling, klassifisering og patofysiologi
- Onkologi
- Palliasjon
- Hjernetumores
Pågående studier
- MENAC : The Multimodal Exercise/Nutrition/Antinflammatory treatment for Cachexia trial
- DIRECT: DIsulfiram REsponse as add-on to ChemoTherapy in recurrent Glioblastoma: A randomized controlled trial
- CAX-24 : utvikling av livskvalitetsskjema for vurdering av kakeksi
- Parenteral ernæring hos pasienter med avansert kreft
- PRAIS: Inflammasjons betydning for utvikling av kakeksi
Veiledningsoppgaver
-
Tittel: Classification and treatment in Cancer Cachexia (Hovedveiler, PhD, Pågående )
-
Tittel: Impact of oncological treatment on quality of life in patients with advanced cancer(Hovedveileder, PhD, Pågående )
-
Tittel: Multidimensional rehabilitation after cancer treatment (Biveileder, PhD, Pågående )
Handlingsprogram
- Medforfatter "Nasjonalt handlingsprogram for hjernekreft"
- Medforfatter "Nasjonalt handlingsprogram for palliasjon"
- Medforfatter ESPEN (European Society for Parenteral and Enteral Nutrition): Guidelines for nutrition in cancer
- Medforfatter ESMO (European Society for Medical Oncology): Guidelines for nutrition in cancer cachexia
Utvalg av undervisiningsoppdrag
- Medisinstudiet ved NTNU
- PhD course in palliative medicine. NTNU. PALC 8001 Module 1
- Master Smerte og palliasjon I KLH 3200, Videreutdanning MDV6010
- HiST, videreutdanning i kreftsykepleie
- 2015 European School of oncology (ESO): Cachexia and Nutrition in Advanced Cancer Patients
- 2017 ESMO Preceptorship on Supportive and Palliative Care
- 2018 og 2019 ESMO Preceptorship on Lung Cancer
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2020) Power comparisons and clinical meaning of outcome measures in assessing treatment effect in cancer cachexia: secondary analysis from a randomised pilot multimodal intervention trial. Frontiers in Nutrition. vol. 7 (326).
- (2020) Exercise and nutrition interventions in patients with head and neck cancer during curative treatment: A systematic review and meta-analysis. Nutrients. vol. 12:3233 (11).
- (2020) Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia. Frontiers in Oncology.
- (2019) Patient interpretation of the Patient-Generated Subjective Global Assessment (PG-SGA) Short Form. Patient Preference and Adherence. vol. 13.
- (2019) A systematic review examining nutrition support interventions in patients with incurable cancer. Supportive Care in Cancer.
- (2019) Food intake by Patient-Generated Subjective Global Assessment (PG-SGA) corresponds to energy and protein intake as well as weight change in patients with advanced cancer. Clinical Nutrition Experimental. vol. 25.
- (2019) Nutritional experiences in head and neck cancer patients. European Journal of Cancer Care. vol. 28 (6).
- (2019) Combining optimal nutrition and exercise in a multimodal approach for patients with active cancer and risk for losing weight: Rationale and practical approach. Nutrition - The International Journal of Applied and Basic Nutritional Sciences. vol. 67-68:110541.
- (2019) Deterioration in muscle mass and physical function differs according to weight loss history in cancer cachexia. Cancers. vol. 11 (12).
- (2019) Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?. Supportive Care in Cancer.
- (2019) Effects of current parenteral nutrition treatment on health-related quality of life, physical function, nutritional status, survival and adverse events exclusively in patients with advanced cancer: A systematic literature review. Critical Reviews in Oncology/Hematology. vol. 139.
- (2019) A prospective study examining cachexia predictors in patients with incurable cancer. BMC Palliative Care. vol. 18:46.
- (2018) Cancer cachexia: Rationale for the MENAC (Multimodal - Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial. BMJ Supportive & Palliative Care. vol. 8.
- (2018) Multimodal behandling av kakeksi hos kreftpasienter. Bestpractice Onkologi/Hematologi. vol. 36.
- (2018) The Palliative Radiotherapy and Inflammation Study (PRAIS) - Protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain. BMC Palliative Care. vol. 17 (110).
- (2018) Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial. F1000 Research. vol. 7.
- (2018) Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials. Acta Oncologica. vol. 57 (11).
- (2018) Endpoints in clinical trials in cancer cachexia: where to start?. Current opinion in supportive and palliative care. vol. 12 (4).
- (2017) Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial. Cancer. vol. 123 (22).
- (2017) ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition. vol. 36 (1).